ERICA CHEVALIER: Open Payments
NPI 1710609862 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 13 payments from 13 companies in 2025. Trend: 2023 $2,706 · 2024 $384 · 2025 $1,229
Food & beverage: $1,229
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $127 |
| Janssen Pharmaceuticals, Inc | 1 | $126 |
| Novo Nordisk Inc | 1 | $123 |
| REVANCE THERAPEUTICS, INC. | 1 | $122 |
| Viatris Specialty LLC | 1 | $115 |
| Boston Scientific Corporation | 1 | $112 |
| ABBVIE INC. | 1 | $97 |
| Axsome Therapeutics, Inc. | 1 | $92 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $86 |
Products named: REZDIFFRA, Kerendia, INVEGA SUSTENNA, Wegovy, DAXXIFY, YUPELRI, WaveWriter Alpha Prime 16, QULIPTA.
Industry payments across NY — which companies pay providers there.
